Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchp33alzheimersbace1ibec

Synthetic peptide P33 cuts brain amyloid 35.6% in Alzheimer's mice

The IBEC-led team modulated rather than fully blocked BACE1, the enzyme whose complete inhibition has failed in clinical trials because of side effects.

PR
By Priya Raman · Science Reporter
Oct 16 11:51 ETSource: Technology Networks

The wire

  1. 01Screening a library of 50 modified peptides in cultured mouse neurons, researchers found P33 halved amyloid beta release and cut BACE1-associated activity by more than 50% without affecting BACE2.
  2. 02Eight weeks of P33 in amyloid-plaque mice reduced brain amyloid beta and cortical and hippocampal plaque area by 35.6%, with no organ damage or inflammation marker changes reported.
  3. 03Results are confined to cell cultures and a transgenic mouse model, published in Bioorganic Chemistry; no human dosing, pharmacokinetic or safety data exist yet.

From the source

Peptide Cut Brain Amyloid Plaques by More Than One-Third in Preclinical Study

We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Read at technologynetworks.com
PeptiPrescribed peptides from $99/moSee all →